Cardiovascular effects of low-dose dexamethasone in very low birth weight neonates with refractory hypotension

Biology of the Neonate

Volumn 89, Issue 2, 2006, Pages 82-87

  Noori, Shahab ^a,b   Siassi, Bijan ^a   Durand, Manuel ^a   Acherman, Ruben ^a   Sardesai, Smeeta ^a   Ramanathan, Rangasamy ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Corticosteroid; Dopamine; Hypotension, pressor resistant; Preterm infants

Indexed keywords

DEXAMETHASONE; DOBUTAMINE; DOPAMINE; INSULIN;

ARTICLE; BIRTH WEIGHT; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INOTROPISM; INTESTINE PERFORATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NEWBORN; PERINATAL PERIOD; PRESSOR RESPONSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINE VOLUME; VERY LOW BIRTH WEIGHT;

CARDIOVASCULAR SYSTEM; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; GESTATIONAL AGE; HUMANS; HYPOTENSION; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; RETROSPECTIVE STUDIES;

EID: 32844475128     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088289     Document Type: Article

References (35)

1. Dasgupta SJ, Gill AB: Hypotension in the very low birthweight infant: the old, the new, and the uncertain. Arch Dis Child Fetal Neonatal Ed 2003;88:F450-F454.
2. Sasidharan P: Role of corticosteroids in neonatal blood pressure homeostasis. Clin Perinatol 1998;25:723-740.
3. Seri I, Evans J: Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 2001;13:116-123.
4. Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK: Variation in prevalence of hypotension, hypertension and vasopressor use in NICUs. J Perinatol 2002;21:272-278.
5. Ng PC, Lee CH, Lam CWK, Ma KC, Fok TF, Chan HIS. Wong E: Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F119-F126.
6. Seri I: Circulatory support of the sick preterm infant. Semin Neonatol 2001;6:85-95.
7. Gill AB, Weindling AM: Randomized controlled trial of plasma protein fraction versus dopamine in hypotensive very low birth weight infants. Arch Dis Child 1993;69:284-287.
8. Gaissmaier RE, Pohlandt F: Single dose dexamethasone treatment of hypotension in preterm infants. J Pediatr 1999;134:701-705.
9. Fauser A, Pohlandt F, Bartmann, Gortner L: Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone. Eur J Pediatr 1993;152:354-356.
10. Helbock HJ, Insoft RM, Conte FA: Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics 1993;92:715-717.
11. Ng PC, Lam CWK, Fok TF, Lee CH, Ma KC, Chan HIS, Wong E: Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed 2001;84:F122-F124.
12. Seri I, Tan R, Evans J: Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 2001;107:1070-1074.
13. Lee MM, Rajagopalan L, Berg GJ, Moshang T Jr: Serum adrenal steroid concentration in premature infants. J Clin Endocrinol Metab 1989;69:1133-1136.
14. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA: Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 1994;78:266-270.
15. Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ: Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr 1996;128:257-263.
16. Botas CM, Kurlat I, Young SM, Sola A: Disseminated Candida infections and intravenous hydrocortisone in preterm infants. Pediatrics 1995;95:883-887.
17. Ramanathan R, Siassi B, Sardesai S, deLemos R: Dexamethasone versus hydrocortisone for hypotension refractory to high dose inotropic agents and incidence of Candida infection in extremely low birth weight infants. Pediatr Res 1996;39:240A.
18. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-F181.
19. Barrington KJ: The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BioMed Central Pediatr 2001;1:1.
20. van der Heide-Jalving M, Kamphuis PJGH, van der Laan MJ, Bahher JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F: Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone. Acta Paediatr 2003;92:827-835.
21. Nuntnarumit P, Yang W, Bada-Ellzey HS: Blood pressure measurements in the newborn. Clin Perinatol 1999;26:981-996.
22. Counsell SJ, Allsop JM, Harrison MC, Larkman DJ, Kennea NL, Kapellou O, Cowan FM, Hajnal JV, Edwards AD, Sci FM, Rutherford MA: Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 2003;112:1-7.
23. Fernandez E, Schrader R, Watterberg K: Prevalence of low cortisol value in term and near-term infants with vasopressor-resistant hypotension. J Perinatol 2005;25:114-118.
24. Hausdroff WP, Caron MG, Lefkowitz RJ: Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990;4:2881-2889.
25. Scott SM, Watterberg KL: Effect of gestational age, postnatal age, and illness on the plasma cortisol concentrations in premature infants. Pediatr Res 1995;37:112-116.
26. Carcillo JA: Nitric oxide production in neonatal and pediatric sepsis. Crit Care Med 1999;27:1063-1065.
27. Bourchier D, Weston PJ: Randomized trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997;76:F174-F178.
28. Kopelman AE, Moise AA, Holbert D, Hegemier SE: A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. J Pediatr 1999;135:345-350.
29. Davies AO, Lefkowitz RJ: Regulation of beta-adrenergic receptors by steroid hormones. Annu Rev Physiol 1984;46:119-130.
30. Hadcock JR, Malbon CC: Regulation of beta-adrenergic receptor by permissive hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 1988;85:8415-8419.
31. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-10047.
32. Wehling M: Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 1997;59:365-393.
33. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, Couser RJ, Garland JS, Rozycki HJ, Leach CL, Backstrom C, Shaffer ML: Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004;114:1649-1657.
34. Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF, Samuels DP, McAuliffe TL: A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999;104:91-99.
35. Pera A, Byun A, Gribar S, Schwartz R, Kumar D, Parimi P: Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams. J Perinatol 2002;22:204-208.